Stifel Nicolaus Sticks to Their Hold Rating for Pennant Group (PNTG)

Stifel Nicolaus analyst Tao Qiu maintained a Hold rating on Pennant Group (PNTGResearch Report) yesterday and set a price target of $17.00. The company’s shares closed yesterday at $16.71.

According to TipRanks, Qiu is an analyst with an average return of -10.9% and a 33.33% success rate. Qiu covers the Healthcare sector, focusing on stocks such as Addus Homecare, Amedisys, and Pennant Group.

Pennant Group has an analyst consensus of Hold, with a price target consensus of $17.00, a 1.74% upside from current levels. In a report released on August 10, Truist Financial also maintained a Hold rating on the stock with a $18.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

The company has a one-year high of $34.19 and a one-year low of $10.07. Currently, Pennant Group has an average volume of 127K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

The Pennant Group, Inc. engages in the provision of healthcare services. It operates through the following segments: Home Health and Hospice Services, Senior Living Services, and All Other. The Home Health and Hospice Services segment provides combination of clinical care services such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services. The Senior Living Services segment deals with assisted and independent living and memory care businesses. The All Other segment includes mobile diagnostic and laboratory services. The company was founded on January 24, 2019 and is headquartered in Eagle, ID.

Read More on PNTG:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More